MADRIGAL PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Madrigal Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Madrigal Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.46M, a 254% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.46M +$1.05M +254% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.59M +$933K +143% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.71M +$1.11M +185% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $1.84M +$1.01M +121% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $411K -$646K -61.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $653K -$43K -6.18% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $602K -$195K -24.5% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $831K -$66K -7.36% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.06M +$60K +6.02% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $696K -$11K -1.56% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $797K +$12K +1.53% Dec 31, 2021 10-K/A 2023-03-03
Q3 2021 $897K +$34K +3.94% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $997K +$477K +91.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $707K +$109K +18.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $785K +$110K +16.3% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $863K +$112K +14.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $520K -$306K -37% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $598K -$332K -35.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $675K Dec 31, 2019 10-K 2021-02-25
Q3 2019 $751K Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $826K Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $930K Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.